Paradeep Phosphates names new MD, Joint MD; reports Q3 FY26 results
Paradeep Phosphates Limited declared its Q3 FY26 results. The company reported consolidated profit after tax of ₹182.06 crore. The Board approved the re-appointment of Mr. N Suresh Krishnan as MD and appointment of Mr. K K Rajeev Nambiar as Joint MD, both for three-year terms starting Feb 16, 2026 and Apr 1, 2026 respectively.
The re-appointment of the Managing Director and the appointment of a Joint Managing Director are significant leadership changes that can impact the company's strategic direction and operations. The financial results are also a key factor for investors.
The announcement includes financial results and key management appointments. While the financial results are routine, the management changes are significant but neutral in sentiment as they are re-appointments and appointments.
Paradeep Phosphates Limited announced the outcome of its Board Meeting held on February 02, 2026.
The Board approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The meeting commenced at 03:30 P.M. (IST) and concluded at 05:45 P.M. (IST).
Key personnel changes were also approved. Mr. N Suresh Krishnan has been re-appointed as Managing Director and Key Managerial Personnel for a period of three years, effective February 16, 2026, subject to member approval. Additionally, Mr. K K Rajeev Nambiar has been appointed as Joint Managing Director and Key Managerial Personnel for a period of three years, effective April 01, 2026, also subject to member approval.
The company reported its financial results for the quarter ended December 31, 2025. For the standalone results, total income was ₹5,779.65 crore, with a profit before tax of ₹233.37 crore and profit after tax of ₹182.05 crore. For the consolidated results, total income was ₹5,779.65 crore, with a profit before tax of ₹233.38 crore and profit after tax of ₹182.06 crore.
An exceptional item of ₹41.30 crore was noted in both standalone and consolidated results, related to the impact of the four new Labour Codes notified by the Government of India. The company is monitoring further developments on these codes.
What to do with a filing like this
Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.